{"SPADE_UN_17161": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17161", "Peptide Name": "P7-4", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "RRRRRRRGGIYLATALAKWALKQGF", "Sequence Length": 25, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C134H226N50O29", "Mass": 3001.55, "PI": 12.0, "Net Charge": 9, "Hydrophobicity": -0.84, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "Electrical potentiation of the membrane permeabilization by new peptides with anticancer properties.", "Pubmed ID": "23262194", "Reference": "Biochim Biophys Acta. 2013 Mar;1828(3)1047-56.", "Author": "Lemeshko VV.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23262194"}], "Frequent Amino Acids": "RAG", "Absent Amino Acids": "CDEHMNOPSUV", "Basic Residues": 9, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 16, "Positive Residues": 9, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_10932", "Similarity": 1.0, "Sequence": "RRR"}, {"SPADE_ID": "SPADE_N_11097", "Similarity": 1.0, "Sequence": "WWRRRRRRRR"}, {"SPADE_ID": "SPADE_N_11098", "Similarity": 1.0, "Sequence": "WWWRRRRRRRR"}]}}}